The Current State Of FDA-Approved AI-Enabled Medical Devices.
Summary
This article provides an overview of the current landscape of AI-enabled medical devices that have received FDA approval, highlighting trends and regulatory progress in healthcare technology.
View Cached Full Text
Cached at: 05/11/26, 04:34 PM
Similar Articles
FDA Shortens Clinical Trial Timelines for Drugs and Medical Devices with AI
The FDA launches a pilot program using Causal AI to shorten clinical trial timelines for drugs and medical devices, potentially reducing trial duration by 20-40% and speeding regulatory approval.
AI in drug discovery — what it is, where we stand and the path forward
This article provides an overview of AI in drug discovery, discussing its current applications and future directions.
Towards Next-Generation Healthcare: A Survey of Medical Embodied AI for Perception, Decision-Making, and Action
This paper systematically surveys the core components of medical embodied AI, emphasizing the coordinated integration of perception, decision-making, and action in clinical environments, and reviews representative applications, datasets, and future research directions.
Article: 'Artificial intelligence in drug discovery — what it is, where we stand and the path forward'
A Nature Reviews Drug Discovery perspective critically reviews AI in drug discovery, noting limited clinical impact and offering recommendations for improving translational relevance.
Trends in AI and Human-AI Interaction in Clinical Trials -- A Hybrid Human-AI Exploration
This paper analyzes temporal and geographical trends in AI terminology in clinical trials from clinicaltrials.gov, using a hybrid human-AI approach with GPT-5.5. It finds increasing AI-related trials, with China and the US leading, and discusses the viability of hybrid screening for human-AI interaction classification.